# Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer

> **NCT02480634** · PHASE4 · UNKNOWN · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 280 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Bone Metastasis

## Interventions

- **DRUG:** Zoledronic acid
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02480634
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06
- **Primary completion:** 2021-09
- **Final completion:** 2022-12
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02480634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02480634, "Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02480634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*